Increasing the selectivity of amikacin in rat peritoneal macrophages using carrier erythrocytes Briones E, Colino CI, Millán CG, Lanao JM. European Journal of Pharmaceutical 4/38:320-324. FI: 2.906 (Q2) Influence of the cytochrome P450 2B6 genotype on population pharmacokinetics of efavirenz in human immunodeficiency virus patients Cabrera SE, Santos D, Valverde MP, Domínguez-Gil A, González F, Luna G, García MJ. Antimicrobial Agents and Chemotherapy 53:2791-2798. FI: 4.802 (Q1) Long-term efficacy and safety of efavirenz dose reduction to 200 mg once daily in Caucasian patient with HIV Cabrera Figueroa S, Iglesias Gómez A, Sánchez Martín A, de la Paz Valverde Merino M, Domínguez-Gil Hurlé A, Cordero Sánchez M. Clinical Drug Investigation 6/30:405-411. FI: 1.414 (Q3) Population pharmacokinetics of albendazole in patients with neurocysticercosis Castro N, Márquez-Caraveo C, Brundage RC, González-Esquivel D, Suárez AM, Góngora F, Jara A, Urizar J, Lanao JM, Jung H. International Journal of Clinical 47(11):679-85. FI: 1.381 (Q3) Vancomycin dosage optimization in patients with malignant haematological disease by pharmacokinetic/ pharmacodynamic analysis Fernández de Gatta Mdel M, Santos Buelga D, Sánchez Navarro A, Domínguez-Gil A, García MJ. Clinical Pharmacokinetics 48(4):273-280. FI: 4.560 (Q1) Evaluation of population pharmacokinetic models for amikacin dosage individualization in critically ill patients Mar Fernández de Gatta MD, Victoria Calvo M, Ardanuy R, Domínguez-Gil A, Lanao JM, Moreno SR. Journal of Pharmacy and Pharmacology 61:1-8. FI: 1.742 (Q3) Hyperhidrosis in association with efavirenz Fuertes A, Cabrera S, Valverde M de L, Domínguez-Gil A. AIDS Patients Care 3/23:143-145. FI: 2.683 (Q2) Study of the factors influencing the encapsulation of zidovudine in rat erythrocytes International Briones E, Colino CI, Lanao JM. Journal of Pharmaceutics 401(1-2):41-6. FI: 2.962 (Q2) The convergence of therapeutic drug monitoring and pharmacogenetic testing to optimize efavirenz therapy Therapeutic Figueroa SC, de Gatta MF, García LH, Hurlé AD, Bernal CB, Correa RS, Sánchez MJ. Drug Monitoring 32:579-585. FI: 2.429 (Q1) Clinical repercussions of analytical interferences fue to aldosterone antagonists in digoxin immnoassays: an assessment Cobo A, Martín-Suarez A, Calvo MV, Domínguez-Gil A, de Gatta MM. Therapeutic Drug Monitoring 32:169-176. FI: 2.429 (Q1)
|
